VYNE Therapeutics (VYNE)
(Delayed Data from NSDQ)
$2.32 USD
+0.02 (0.87%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $2.32 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.24 | 0.00% |
Earnings Summary
For their last quarter, VYNE Therapeutics (VYNE) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.50 per share. This reflects a positive earnings surprise of 60.00%. Look out for VYNE's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year increase of 86.21%.
Earnings History
Price & Consensus
Zacks News for VYNE
What Makes VYNE Therapeutics Inc. (VYNE) a New Buy Stock
VYNE: What are Zacks experts saying now?
Zacks Private Portfolio Services